| Title | Overexpression of LBH is associated with poor prognosis in human hepatocellular carcinoma |
| Authors | Chen, Jiewei Huang, Chuqiang Chen, Keming Li, Shuman Zhang, Xinke Cheng, Jun Cai, Muyan Xiao, Yongbo |
| Affiliation | Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Canc Ctr, Guangzhou, Guangdong, Peoples R China. Sun Yat Sen Univ, Dept Pathol, Canc Ctr, 651 Dongfeng Rd East, Guangzhou 510060, Guangdong, Peoples R China. Peking Univ, Dept Pathol, Shenzhen Hosp, Shenzhen, Peoples R China. Shenzhen Peoples Hosp, Dept Pathol, Shenzhen, Peoples R China. |
| Keywords | LBH hepatocellular carcinoma immunohistochemistry prognosis SIGNALING PATHWAY HEART GENE |
| Issue Date | 2018 |
| Publisher | ONCOTARGETS AND THERAPY |
| Citation | ONCOTARGETS AND THERAPY. 2018, 11, 441-448. |
| Abstract | Purpose: Limb-bud and heart (LBH) levels are correlated with adverse survival in several malignancies; however, their significance in hepatocellular carcinoma (HCC) remains unclear. The objective of this study was to determine the association between LBH status and clinical outcomes. Methods: We selected 226 patients with HCC who were treated surgically between 2003 and 2010 at a single academic center. Immunohistochemistry (IHC) was used to detect the protein expression of LBH in HCC samples. Receiver operating characteristic (ROC) curve analysis, Spearman's rank correlation, Kaplan-Meier plots, and the Cox proportional hazards regression model were used to analyze the data. Results: A high expression of LBH was detected in 20 (8.8%) of 226 HCC samples. Correlation analysis demonstrated that LBH in HCC was significantly correlated with aspartate aminotransferase (AST)/alanine aminotransferase (ALT) levels and clinical stages (P<0.05). In the Kaplan-Meier analysis, the mean survival time of patients with low levels of LBH was longer than that for those with high levels of LBH (P<0.05). The 3-year overall survival rate was 20% for patients with HCC and high levels of LBH versus 67% for patients with HCC and low levels of LBH. In the multivariate analysis, AST/ALT level, clinical stage, tumor relapse, and the level of LBH were the independent prognostic factors for overall survival (P<0.05). Conclusion: Overexpression of LBH might contribute to the development and progression of HCC. LBH could be a novel prognostic marker for HCC. |
| URI | http://hdl.handle.net/20.500.11897/505726 |
| ISSN | 1178-6930 |
| DOI | 10.2147/OTT.S152953 |
| Indexed | SCI(E) PubMed |
| Appears in Collections: | 深圳医院 |
